-transparent.png){kind=logo}
One of the structural posttranslational modifications contributing to the formation of insoluble, and protease-resistant protein deposits in Alzheimer's disease (AD), such as neurofibrillary tangles (NFT) and beta-amyloid plaques are 'advanced glycation endproducts' (AGE). Using a polyclonal antibody against AGE in frozen sections of fixed brain tissue from Alzheimer's disease patients, AGE were identified in a further characteristic protein deposit in AD, namely in Hirano bodies. AGE are localized to ovoid, spherical, and rod-like Hirano bodies in the hippocampus, particularly numerous in the stratum lacunosum-moleculare of CA1. Since Hirano bodies are known to contain mainly cytoskeletal and cytoplasmic components and are localized within the soma of neurons our study suggests that AGE formation and intracellular protein crosslinking represent early stages during neuronal degeneration.
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
February 1997,
Brain research. Brain research reviews,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
April 2002,
Neuroreport,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
January 1996,
Life sciences,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
January 1997,
The Kaohsiung journal of medical sciences,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
May 2011,
Neurobiology of aging,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
June 2005,
Current drug targets. CNS and neurological disorders,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
November 2001,
Brain research,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
April 1995,
Neuroreport,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
January 2011,
Arthritis research & therapy,
G Münch, and
A M Cunningham, and
P Riederer, and
E Braak
February 2013,
Current opinion in lipidology,
